Peri-operative management of direct Xa and IIa inhibitors for dermatologic surgery: A survey of current practice among French dermatologists
J Eur Acad Dermatol Venereol
.
2023 Sep;37(9):e1144-e1146.
doi: 10.1111/jdv.19154.
Epub 2023 May 10.
Authors
Q Samaran
1
,
M Lacombe
2
3
,
O Cogrel
4
,
M Chapalain
5
,
A Le Guern
6
,
F Habib
7
Affiliations
1
Department of Dermatology, University Hospital of Montpellier and University of Montpellier, Montpellier, France.
2
Department of Dermatology, Hôpital Henri-Mondor AP-HP, Créteil, France.
3
Department of Dermatology, Hôpital Saint Camille, Bry-sur-Marne, France.
4
Department of Dermatology, Hôpital Saint André, University Hospital of Bordeaux and University of Bordeaux, Bordeaux, France.
5
Department of Dermatology, Hôpital Ambroise-Paré AP-HP, Boulogne-Billancourt, France.
6
Department of Dermatology, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France.
7
Skin Cancer Surgery Center, Avignon, France.
PMID:
37102461
DOI:
10.1111/jdv.19154
No abstract available
Publication types
Letter
MeSH terms
Anticoagulants*
Dermatologic Surgical Procedures
Dermatologists*
Factor Xa Inhibitors
Humans
Surveys and Questionnaires
Substances
Anticoagulants
Factor Xa Inhibitors